• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管消融心房颤动 5 年及以上后无房性心律失常和其他临床结局:系统评价和荟萃分析。

Freedom from atrial arrhythmia and other clinical outcomes at 5 years and beyond after catheter ablation of atrial fibrillation: a systematic review and meta-analysis.

机构信息

Greater Brisbane Clinical School, Medical School, The University of Queensland, Chermside, QLD 4032, Australia.

Department of Cardiology, The Prince Charles Hospital, Chermside, QLD 4032, Australia.

出版信息

Eur Heart J Qual Care Clin Outcomes. 2023 Aug 7;9(5):447-458. doi: 10.1093/ehjqcco/qcad037.

DOI:10.1093/ehjqcco/qcad037
PMID:37336617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10658515/
Abstract

AIMS

Catheter ablation of atrial fibrillation (AF) is now a mainstream procedure although long-term outcomes are uncertain. We performed a systematic review and meta-analysis of procedural outcomes at 5 years and beyond.

METHODS AND RESULTS

We searched PubMed and Embase and after the screening, identified 73 studies (67 159 patients) reporting freedom from atrial arrhythmia, all-cause death, stroke, and major bleeding at ≥5 years after AF ablation. The pooled mean age was 59.7y, 71.5% male, 62.2% paroxysmal AF, and radiofrequency was used in 78.1% of studies. Pooled incidence of freedom from atrial arrhythmia at 5 years was 50.6% (95%CI 45.5-55.7%) after a single ablation and 69.7% [95%CI (confidence interval) 63.8-75.3%) after multiple procedures. The incidence was higher among patients with paroxysmal compared with non-paroxysmal AF after single (59.7% vs. 33.3%, p = 0.002) and multiple (80.8% vs. 60.6%, p < 0.001) ablations but was comparable between radiofrequency and cryoablation. Pooled incidences of other outcomes were 6.0% (95%CI 3.2-9.7%) for death, 2.4% (95%CI 1.4-3.7%) for stroke, and 1.2% (95%CI 0.8-2.0%) for major bleeding at 5 years. Beyond 5 years, freedom from arrhythmia recurrence remained largely stable (52.3% and 64.7% after single and multiple procedures at 10 years), while the risk of stroke and bleeding increased over time.

CONCLUSION

Nearly 70% of patients having multiple ablations remained free from atrial arrhythmia at 5 years, with the incidence slightly decreasing beyond this period. Risk of death, stroke, and major bleeding at 5 years were low but increased over time, emphasizing the importance of long-term thromboembolism prevention and bleeding risk management.

摘要

目的

尽管房颤(AF)导管消融的长期疗效尚不确定,但目前它已成为一种主流治疗方法。我们对消融术后 5 年及以上的手术结果进行了系统评价和荟萃分析。

方法和结果

我们检索了 PubMed 和 Embase,并在筛选后,确定了 73 项研究(67159 例患者),这些研究报告了 AF 消融术后 5 年及以上时的心房心律失常、全因死亡、卒中和大出血的无事件率。汇总的平均年龄为 59.7 岁,71.5%为男性,62.2%为阵发性 AF,78.1%的研究中使用了射频消融。单次消融后 5 年的无房性心律失常发生率为 50.6%(95%置信区间 45.5-55.7%),多次消融后为 69.7%[95%置信区间(置信区间)63.8-75.3%]。与非阵发性 AF 相比,阵发性 AF 患者在单次(59.7%比 33.3%,p=0.002)和多次(80.8%比 60.6%,p<0.001)消融后无房性心律失常的发生率更高,但射频与冷冻消融之间无差异。5 年时其他结局的发生率分别为死亡 6.0%(95%置信区间 3.2-9.7%)、卒 2.4%(95%置信区间 1.4-3.7%)和大出血 1.2%(95%置信区间 0.8-2.0%)。5 年以上,心律失常复发的无事件率基本保持稳定(单次消融 10 年后为 52.3%和 64.7%,多次消融后为 52.3%和 64.7%),而卒中和出血的风险随时间而增加。

结论

近 70%的多次消融患者在 5 年内无房性心律失常,在此期间后发生率略有下降。5 年时的死亡率、卒中和大出血风险较低,但随时间推移而增加,强调了长期血栓栓塞预防和出血风险管理的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/001d/10658515/19f495d39e33/qcad037fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/001d/10658515/dc46f1c014db/qcad037fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/001d/10658515/578b24756d5f/qcad037fig2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/001d/10658515/a9b190d63e9f/qcad037fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/001d/10658515/19f495d39e33/qcad037fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/001d/10658515/dc46f1c014db/qcad037fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/001d/10658515/578b24756d5f/qcad037fig2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/001d/10658515/a9b190d63e9f/qcad037fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/001d/10658515/19f495d39e33/qcad037fig4.jpg

相似文献

1
Freedom from atrial arrhythmia and other clinical outcomes at 5 years and beyond after catheter ablation of atrial fibrillation: a systematic review and meta-analysis.导管消融心房颤动 5 年及以上后无房性心律失常和其他临床结局:系统评价和荟萃分析。
Eur Heart J Qual Care Clin Outcomes. 2023 Aug 7;9(5):447-458. doi: 10.1093/ehjqcco/qcad037.
2
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.导管消融与抗心律失常药物治疗对心房颤动患者死亡率、卒中和出血及心搏骤停的影响:CABANA 随机临床试验。
JAMA. 2019 Apr 2;321(13):1261-1274. doi: 10.1001/jama.2019.0693.
3
Efficacy and safety of left atrial appendage electrical isolation during catheter ablation of atrial fibrillation: an updated meta-analysis.经导管消融治疗心房颤动时左心耳电隔离的疗效和安全性:一项更新的荟萃分析。
Europace. 2021 Feb 5;23(2):226-237. doi: 10.1093/europace/euaa266.
4
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
5
Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis.房颤导管消融的长期疗效:系统评价和荟萃分析。
J Am Heart Assoc. 2013 Mar 18;2(2):e004549. doi: 10.1161/JAHA.112.004549.
6
Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint.以房颤终止作为终点的导管消融持续性房颤的 5 年结果。
Circ Arrhythm Electrophysiol. 2015 Feb;8(1):18-24. doi: 10.1161/CIRCEP.114.001943. Epub 2014 Dec 20.
7
Sequential hybrid ablation vs. surgical CryoMaze alone for treatment of atrial fibrillation: results of multicentre randomized controlled trial.序贯杂交消融与单纯冷冻迷宫术治疗心房颤动的多中心随机对照研究结果。
Europace. 2024 Feb 1;26(2). doi: 10.1093/europace/euae040.
8
Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.肥厚型心肌病患者房颤的导管消融治疗:一项系统评价和荟萃分析
Heart. 2016 Oct 1;102(19):1533-43. doi: 10.1136/heartjnl-2016-309406. Epub 2016 May 27.
9
Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation.贝叶斯网络荟萃分析比较冷冻消融、射频消融和抗心律失常药物作为心房颤动的初始治疗方法。
J Cardiovasc Electrophysiol. 2022 Feb;33(2):197-208. doi: 10.1111/jce.15308. Epub 2021 Dec 11.
10
Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.采用逐步法消融持续性心房颤动 5 年后的随访及成功的预测因素。
Circ Arrhythm Electrophysiol. 2015 Apr;8(2):308-17. doi: 10.1161/CIRCEP.114.001672. Epub 2015 Mar 5.

引用本文的文献

1
Association Between Left Atrial Epicardial Adipose Tissue Attenuation Assessed by Cardiac Computed Tomography and Atrial Fibrillation Recurrence Following Catheter Ablation: A Systematic Review and Meta-Analysis.心脏计算机断层扫描评估的左心房心外膜脂肪组织衰减与导管消融术后房颤复发之间的关联:一项系统评价和荟萃分析。
J Clin Med. 2025 Jul 6;14(13):4771. doi: 10.3390/jcm14134771.
2
Digital Twin Models in Atrial Fibrillation: Charting the Future of Precision Therapy?心房颤动中的数字孪生模型:描绘精准治疗的未来?
J Pers Med. 2025 Jun 16;15(6):256. doi: 10.3390/jpm15060256.
3
Challenges and Opportunities for Atrial Fibrillation Management.

本文引用的文献

1
Outcomes of catheter ablation versus antiarrhythmic therapy in patients with atrial fibrillation: a systematic review and meta-analysis.导管消融与抗心律失常治疗对心房颤动患者的疗效:一项系统评价和荟萃分析。
J Interv Card Electrophysiol. 2022 Dec;65(3):773-802. doi: 10.1007/s10840-022-01365-z. Epub 2022 Sep 3.
2
Benefits and Risks Associated with Long-term Oral Anticoagulation after Successful Atrial Fibrillation Catheter Ablation: Systematic Review and Meta-analysis.成功房颤导管消融后长期口服抗凝的获益与风险:系统评价和荟萃分析。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221118480. doi: 10.1177/10760296221118480.
3
心房颤动管理的挑战与机遇
Cardiol Discov. 2025 Jun;5(2):149-161. doi: 10.1097/CD9.0000000000000155. Epub 2025 Apr 10.
4
Epigenetic Drivers of Atrial Fibrillation: Mechanisms, Biomarkers, and Therapeutic Targets.心房颤动的表观遗传驱动因素:机制、生物标志物及治疗靶点
Int J Mol Sci. 2025 May 29;26(11):5253. doi: 10.3390/ijms26115253.
5
Correlation between diagnosis-to-ablation time and atrial fibrillation recurrence: a systematic review and meta-analysis.诊断至消融时间与房颤复发之间的相关性:一项系统评价和荟萃分析。
J Interv Card Electrophysiol. 2025 Feb 21. doi: 10.1007/s10840-025-02015-w.
6
Feasibility and safety of zero-fluoro, "apron-less" approach to repeat pulmonary vein isolation procedures using radiofrequency energy after initial cryoballoon ablation.初次冷冻球囊消融术后采用射频能量进行零氟、“无围领”方法重复肺静脉隔离术的可行性和安全性。
Sci Rep. 2025 Feb 4;15(1):4280. doi: 10.1038/s41598-025-87940-6.
7
Catheter Ablation in Atrial Fibrillation: Recent Advances.心房颤动的导管消融:最新进展
J Clin Med. 2024 Dec 17;13(24):7700. doi: 10.3390/jcm13247700.
8
Comparing simultaneous hybrid ablation with stand-alone thoracoscopic surgical ablation for the treatment of non-paroxysmal atrial fibrillation: a prospective randomized controlled trial.同期杂交消融与单纯胸腔镜手术消融治疗非阵发性心房颤动的比较:一项前瞻性随机对照试验。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae226.
9
Long-term outcomes after hospitalization for atrial fibrillation or flutter.心房颤动或房扑住院治疗后的长期结局。
Eur Heart J. 2024 Jun 28;45(24):2133-2141. doi: 10.1093/eurheartj/ehae204.
10
The outcomes of concomitant catheter ablation in non-mitral valve cardiac surgery-a systematic review and meta-analysis of the literature.非二尖瓣心脏手术中同期导管消融的结果——文献的系统评价与荟萃分析
Ann Cardiothorac Surg. 2024 Mar 29;13(2):108-116. doi: 10.21037/acs-2023-afm-17. Epub 2024 Feb 27.
An Observational Study of Clinical and Health System Factors Associated With Catheter Ablation and Early Ablation Treatment for Atrial Fibrillation in Australia.
一项观察性研究:澳大利亚与导管消融术及房颤早期消融治疗相关的临床和医疗系统因素。
Heart Lung Circ. 2022 Sep;31(9):1269-1276. doi: 10.1016/j.hlc.2022.04.049. Epub 2022 May 25.
4
Ten-year trends in mortality and complications following catheter ablation of atrial fibrillation.导管消融治疗心房颤动后 10 年的死亡率和并发症趋势。
Eur Heart J Qual Care Clin Outcomes. 2022 Jun 6;8(4):398-408. doi: 10.1093/ehjqcco/qcab102.
5
High Cerebrovascular Thromboembolic Event Rate Long after Unsuccessful Catheter Ablation for Atrial Fibrillation.房颤导管消融失败后很长时间内脑血管血栓栓塞事件发生率仍高。
J Atr Fibrillation. 2020 Oct 31;13(3):2294. doi: 10.4022/jafib.2294. eCollection 2020 Oct-Nov.
6
Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation.左心耳大小是持续性心房颤动患者射频导管消融术后心房颤动复发的标志物。
Clin Cardiol. 2022 Mar;45(3):273-281. doi: 10.1002/clc.23748. Epub 2021 Nov 19.
7
Remote magnetic navigation versus manual catheter ablation of atrial fibrillation: A single center long-term comparison.远程磁导航与手动导管消融治疗心房颤动:单中心长期比较。
Pacing Clin Electrophysiol. 2022 Jan;45(1):14-22. doi: 10.1111/pace.14392. Epub 2021 Oct 31.
8
Utilisation and safety of catheter ablation of atrial fibrillation in public and private sector hospitals.公立和私立医院中心房颤动导管消融的使用和安全性。
BMC Health Serv Res. 2021 Aug 28;21(1):883. doi: 10.1186/s12913-021-06874-7.
9
Impact of abdominal obesity on outcomes of catheter ablation in Korean patients with atrial fibrillation.腹型肥胖对韩国心房颤动患者导管消融结局的影响。
Int J Clin Pract. 2021 Oct;75(10):e14696. doi: 10.1111/ijcp.14696. Epub 2021 Aug 6.
10
Arrhythmia Recurrence After Atrial Fibrillation Ablation: Impact of Warfarin vs. Non-Vitamin K Antagonist Oral Anticoagulants.心房颤动消融术后心律失常复发:华法林与非维生素K拮抗剂口服抗凝剂的影响
Cardiovasc Drugs Ther. 2022 Oct;36(5):891-901. doi: 10.1007/s10557-021-07200-3. Epub 2021 May 18.